Search Within

Victoria Sarah Brennan

Formats
  1. Meeting Abstract (19)
  2. Journal Article (10)
  3. Book Section (1)
  4. Review (1)
Groups
  1. Radiation Oncology, Department of (31)
  2. Medical Physics (14)
  3. Radiotherapy Physics Service (13)
  4. Survivorship Research (13)
  5. GME, Radiation Oncology (11)
  6. Graduate Medical Education (11)

More Groups

People
  1. Marisa Kollmeier (8)
  2. Michael Zelefsky (8)
  3. Sean McBride (8)
  4. Zhigang Zhang (8)
  5. Neelam Tyagi (7)
  6. Antonio Damato (6)

More People

Years
  1. 2025 (1)
  2. 2024 (7)
  3. 2023 (7)
  4. 2022 (8)
  5. 2021 (6)
  6. 2019 (2)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (13)
  2. Radiotherapy and Oncology (4)
  3. Medical Physics (3)
  4. Advances in Radiation Oncology (2)
  5. Brachytherapy (2)
  6. Journal of Clinical Oncology (2)

More Publications

Publishers
  1. Elsevier Inc. (19)
  2. American Association of Physicists in Medicine (3)
  3. Elsevier Science, Inc. (3)
  4. American Society of Clinical Oncology (2)
  5. American College of Medical Physics (1)
  6. Springer (1)

More Publishers

Results (31)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Focal dose intensification to the dominant intraprostatic lesion (DIL) using an MR-linac adaptive-planning approach for prostate cancer: Dosimetric outcomes and early toxicity
    Meeting Abstract

    Brennan, V. S.; Burleson, S.; Kostrzewa, C.; Scripes, P. G.; Subashi, E.; Zhang, Z.; Tyagi, N.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Combined brachytherapy and ultra-hypofractionated radiotherapy for intermediate-risk prostate cancer: Comparison of toxicity outcomes using a high-dose-rate (HDR) versus low-dose-rate (LDR) brachytherapy boost
    Journal Article

    Kollmeier, M. A.; Gorovets, D.; Flynn, J.; McBride, S.; Brennan, V.; Beaudry, J.; Cohen, G.; Damato, A.; Zhang, Z.; Zelefsky, M. J.
    Brachytherapy (2022)

    Fulltext@MSK | Save
  • Personalized treatment selection leads to low rates of local salvage therapy for bone metastases
    Journal Article

    Mathis, N. J.; Doyle, C. J.; Rosen, D. B.; Wijetunga, N. A.; Vaynrub, M.; Bartelstein, M.; Guttmann, D. M.; Brennan, V. S.; Yamada, Y. J.; Gillespie, E. F.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Early outcomes of high-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancer
    Journal Article

    Gorovets, D.; Hopkins, M.; Kollmeier, M.; Moore, A.; Goel, A.; Shasha, D.; Brennan, V.; McBride, S.; Cohen, G.; Damato, A. L.; more...
    Brachytherapy (2021)

    Fulltext@MSK | Save
  • Stereotactic magnetic resonance guided adaptive radiation therapy for abdominopelvic metastases
    Meeting Abstract

    Yang, D. D.; Brennan, V. S.; Huynh, E.; Williams, C. L.; Han, Z.; Ampofo, N.; Vastola, M.; Leeman, J. E.; Mak, R. H.; Singer, L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Quantitative relaxometry for ultra-hypofractionated MR-guided radiotherapy to the prostate and DIL: A feasibility study
    Meeting Abstract

    Subashi, E.; LoCastro, E.; Brennan, V.; Apte, A.; Zelefsky, M.; Tyagi, N.
    Medical Physics (2021)

    Fulltext@MSK | Save
  • Recommendations for previous treatment assessment of non-CT based IVRT brachytherapy
    Meeting Abstract

    Aramburu Nunez, D.; Brennan, V.; Kollmeier, M.; Alektiar, K.; Damato, A.; Cohen, G.
    Medical Physics (2021)

    Fulltext@MSK | Save
  • Feasibility of adapt-to-position treatment of prostate patients undergoing ultra-hypofractionated MR-guided adaptive radiotherapy
    Meeting Abstract

    Burleson, S.; Brennan, V.; Zelefsky, M.; Tyagi, N.
    Medical Physics (2021)

    Fulltext@MSK | Save
  • Evaluating the role of stereotactic body radiation therapy with respect to androgen receptor signaling inhibitors for metastatic prostate cancer
    Meeting Abstract

    Brennan, V.; Spektor, A.; Sweeney, C.; Choudhury, A. D.; Rathkopf, D. E.; Pomerantz, M.; Hertan, L. M.; Martin, N. E.; Nguyen, P. L.; Balboni, T. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Is there a clinically meaningful change in anatomy during planning of US HDR prostate brachytherapy?
    Meeting Abstract

    David, A.; Brennan, V.; Cohen, G.; Damato, A.
    Radiotherapy and Oncology (2019)

    Fulltext@MSK | Save